USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • Oct 2020
  • Country Level
  • 350 Pages
  • No of Tables: 44
  • No of Figures: 45

USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts, Vasodialtion Devices, Filtration Devices and Surgical System), Target (Trabecular Meshwork, Suprachoroidal Space, Subconjunctival Filtration and Reducing Aqueous Production), Material Type (Titanium, STAINLESS Steel, Polyamide, Gelatin, Silicone), Surgery type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), Glaucoma Type (Open Angle Glaucoma, Acute Angle Closure Glaucoma, Secondary Glaucoma, Normal Tension Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales) Industry Trends and Forecast to 2027

Market Analysis and Insights : USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market

USA micro invasive glaucoma surgery (MIGS) devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 32.5% in the forecast period of 2020 to 2027 and expected to reach USD 2,672.9 million by 2027. Increases case of chronic diseases and increasing geriatric population are the major drivers of market which propelled the demand of the market in the forecast period.

MIGS stands for micro-invasive glaucoma surgery which is useful in the treatment of glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier and it also prevents the complications of conventional surgery. These procedures are used to lower the intraocular pressure of the eye to prevent the damage of the optic nerve.

The USA in micro invasive glaucoma surgery (MIGS) devices market is growing primarily due to increasing focus on the high prevalence of the disorders among old aged group. The rising social media concerns are also acting as significant growth factors for the market.

Micro invasive glaucoma surgery (MIGS) is used to treat open-angle glaucoma. Initially, to treat open angle glaucoma (OAG), medication was given that reduced aqueous humor production or increased aqueous humor outflow. For mild to moderate open angle glaucoma (OAG), traditionally pharmacologic and laser treatment was performed. With the coming of micro invasive glaucoma surgery (MIGS) procedures, new options were created for those who were not fit for conventional surgery type. An increase in the population of geriatrics and increasing government initiatives for the prevention of blindness are giving a boost to the market. The rapid transition from glaucoma medication to minimally invasive glaucoma surgeries is creating growth opportunities for the manufacturer of micro invasive glaucoma surgery (MIGS) devices. However, poor reimbursement facilities act as an obstacle to the market.

The USA micro invasive glaucoma surgery (MIGS) devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKETUSA Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope and Market Size

USA micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of product, target, surgery type, end user, glaucoma type, material type and distribution channel. The growth among segments helps you to analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS stents, MIGS shunts, vasodialtion devices, filtration devices and surgical system. In 2020, MIGS stents segment is expected to dominate the market due to the high adoption of MIGS stents in micro invasive glaucoma surgery (MIGS) for lowering IOP in difficult-to-treat patients.
  • On the basis of target, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into trabecular meshwork, suprachoroidal space, subconjunctival filtration and reducing aqueous production. In 2020, the rising incidence of glaucoma globally is the driving factor for trabecular meshwork segment in the market. However, high cost of surgical procedures may hamper the growth of the market.
  • On the basis of surgery type, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma. In 2020, glaucoma in conjunction with cataract segment is expected to dominate the market due to increasing adoption of micro invasive glaucoma surgery (MIGS) procedure conjunction with cataract in the developed and developing countries.
  • On the basis of end user, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) and others. In 2020, the rising incidence of glaucoma globally is the driving factor for hospital outpatient departments (HOPD) segment in the market and also outpatient departments (HOPD) are one of the first contact point and most trustable option for the patients in the various countries.
  • On the basis of glaucoma type, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into open angle glaucoma, acute angle closure glaucoma, secondary glaucoma, normal tension glaucoma. In 2020, open angle glaucoma is dominating due to increasing open angle glaucoma patient and rising awareness related to advantage MIGS are driving the market growth of segment during the forecast period.
  • On the basis of material type, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into titanium, stainless steel, polyamide, gelatin and silicone. In 2020, high adoption of titanium based product in minimally invasive glaucoma surgery and consumer preference are driving the titanium segment growth during the forecast period.
  • On the basis of distribution channel, the USA micro invasive glaucoma surgery (MIGS) devices market is segmented into direct tender and retail sales. In 2020, direct tender segment is expected to dominate the market as most of the of the hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS) prefers direct tender for seeking the benefits of bulk buying, discounts and easy availability of products.

The country section of the USA micro invasive glaucoma surgery (MIGS) devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

The Increase in the Geriatric Population is Propelling the USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market Growth

USA micro invasive glaucoma surgery (MIGS) devices market also provides you with detailed market analysis for every country growth in particular industry with liposuction devices sales, impact of advancement in the USA micro invasive glaucoma surgery (MIGS) devices market and changes in regulatory scenarios with their support for the USA micro invasive glaucoma surgery (MIGS) devices market. The data is available for historic period 2010 to 2018.

Competitive Landscape and USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis

USA micro invasive glaucoma surgery (MIGS) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to USA micro invasive glaucoma surgery (MIGS) devices market.

The major players covered in the USA micro invasive glaucoma surgery (MIGS) devices market report are Glaukos Corporation, Allergan, Ivantis, Inc., Ellex (Nova Eye Medical), Alcon, BVI, Johnson and Johnson Surgical Vision, Inc., MicroSurgical Technology, MOLTENO Ophthalmic Ltd, New World Medical, Inc., Santen Pharmaceutical Co., Ltd., and Sight Sciences among other domestic and European players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the USA micro invasive glaucoma surgery (MIGS) devices market.

  • In April 2020, Allergan announced that China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN Gel Stent for the patients suffering from refractory glaucoma, as this is the first product to get the approval in China, which will lead to increased revenue generation in the market.
  • In November 2019, Glaukos Corporation announced the acquisition of Avedro, Inc., which also works in the development of products for corneal health. This acquisition has led to widening of product portfolio. Also, the revenue generation of the company is more in the market.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the warts treatment market which also provides the benefit for organisation to improve their offering for USA micro invasive glaucoma surgery (MIGS) devices.

Customization Available: USA Micro Invasive Glaucoma Surgery (MIGS) Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 2 USA MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 USA MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 USA VASODIALTION DEVICES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 USA FILTRATION DEVICES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 USA FILTRATION DEVICES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 8 USA TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 USA SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 USA SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 USA REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 13 USA GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 USA STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 16 USA HOSPITAL OUTPATIENT DEPARTMENTS (HOPD) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 USA OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 USA AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 USA OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE 2018-2027 (USD MILLION)

TABLE 21 USA OPEN ANGLE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 USA ACUTE ANGLE CLOSURE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 USA SECONDARY GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 USA NORMAL TENSION GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY MATERIAL TYPE 2018-2027 (USD MILLION)

TABLE 26 TITANIUM IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 USA STAINLESS STEELIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 USA POLYAMIDE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 USA GELATIN IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 USA SILICONE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 USA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 32 USA DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 USA RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 35 U.S.MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, MIGS STENTS BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 36 U.S.MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, MIGS SHUNTS BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 37 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2018-2027 (USD MILLION)

TABLE 38 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 39 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET,GLAUCOMA IN CONJUNCTION WITH CATARACT BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 40 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET,STAND-ALONE GLAUCOMA BY SURGERY TYPE, 2018-2027 (USD MILLION)

TABLE 41 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 42 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2018-2027 (USD MILLION)

TABLE 43 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY MATERIAL TYPE, 2018-2027 (USD MILLION)

TABLE 44 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions